beLAB 2122: Translational BRIDGE partnership to develop bifunctional degrader
A oncology project from Goethe University was now chosen for funding within the beLAB2122 BRIDGE partnership. On the academic side, the...
beLAB 2122: Translational BRIDGE partnership to develop bifunctional degrader
1st German Chemical Biology Lecturship
Third ERC Advanced Grant to Ivan Đikić
FCI Professorship for PROXIDRUGS member Manuel Kaulich
Whitepaper: Strategic collaboration between academia and industry enables drug discovery
PROXIDRUGS project leader Ole Pless publishes new CNS entry routes for SARS-CoV-2
Review by Felix Hausch on clues to molecular glues
Christian Münch selected as EMBO Young Investigator
Ivan Đikić elected to the Academy of Sciences and Literature
PROXIDRUGS project leaders Ivan Đikić and Stefan Knapp are Highly Cited Researchers 2021